TT virus infection in Israeli patients with fulminant hepatic failure

Vox Sanguinis

Volumn 79, Issue 4, 2000, Pages 242-245

  Safadi, Rifaat ^a   Ergunay, Koray ^a,b   Ilan, Yaron ^a   Klein, Athalia ^a   Shouval, Daniel ^a   Manny, Noga ^a   Harush, Nissim ^a   Galun, Eithan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; HUMAN; LIVER FAILURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROPREVALENCE; TORQUE TENO VIRUS; VIRUS DETECTION; VIRUS GENE; VIRUS HEPATITIS;

ADOLESCENT; ADULT; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA VIRUS INFECTIONS; FEMALE; HUMANS; INFANT; ISRAEL; LIVER FAILURE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREVALENCE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TORQUE TENO VIRUS;

EID: 0034517297     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056738     Document Type: Article

References (14)

1. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
2. Prevalence of TTV DNA among children with a history of transfusion or liver disease
3. Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients
4. Detection of a novel DNA virus (TTV) in blood donor and blood products
5. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt
6. Infection with an unenveloped DNÅ virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA
7. Genotypes of TT virus (TTV) compared between liver disease patients and healthy individuals using a new PCR system capable of differentiating 1a and 1b types from others
8. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology
9. Early indicators of prognosis in fulminant hepatic failure
10. Acute liver failure
11. GBV-C virus and fulminant hepatic failure
12. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis
13. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion nonA-G hepatitis
14. Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals